Xylocaine Injection, Solution
Product Images NDC 65219-812

9 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 65219-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure 1 (Xyl03 0002 01)

Structure 1 (Xyl03 0002 01)
Chemical structure of Lidocaine Hydrochloride showing the molecular arrangement of atoms including aromatic ring, amide group, and hydrochloride component.*
FDA Label Image

Structure 2 (Xyl03 0002 02)

Structure 2 (Xyl03 0002 02)
Chemical structure diagram of lidocaine hydrochloride, showing its aromatic ring with hydroxyl groups and side chain consistent with the active ingredient in Xylocaine MPF injection solution.*
FDA Label Image

Fresenius Kabi Logo (Xyl03 0002 03)

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Label for Xylocaine MPF 1% (lidocaine hydrochloride injection, USP) solution. It contains 20 mg per 2 mL (10 mg per mL) in a 2 mL single dose vial. Indicated for infiltration and nerve block including caudal and epidural use. The product is labeled as methylparaben-free and distributed by Fresenius Kabi USA, LLC, Lake Zurich, IL.*
FDA Label Image

Package Label – Principal Display Panel – Xylocaine – Mpf 2 mL Single Dose Vial Tray Label (Xyl03 0002 05)

Package Label – Principal Display Panel – Xylocaine – Mpf 2 mL Single Dose Vial Tray Label (Xyl03 0002 05)
Label for Xylocaine-MPF (lidocaine HCl injection, USP) 1% solution, 20 mg per 2 mL (10 mg per mL) in single-dose 2 mL vials. Intended for infiltration and nerve block including caudal and epidural use. The label states it is methylparaben free, sterile, nonpyrogenic, and contains lidocaine HCl 10 mg, sodium chloride 7 mg per mL. Manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Xylocaine MPF (lidocaine hydrochloride injection, USP) 20 mg/mL (2%) injection solution, 5 mL single dose vial. Label includes NDC 65219-814-01, use instructions for infiltration and nerve block including caudal and epidural use, methylparaben free. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL. Storage and sterility information also shown.*
FDA Label Image

Package Label – Principal Display Panel– Xylocaine – Mpf 5 mL Single Dose Vial Tray Label (Xyl03 0002 07)

Package Label – Principal Display Panel– Xylocaine – Mpf 5 mL Single Dose Vial Tray Label (Xyl03 0002 07)
Label for Xylocaine-MPF 2% (Lidocaine HCl Injection, USP) injection solution, 20 mg/mL strength, supplied in a 5 mL single-dose vial. The label states the product is methylparaben free, intended for infiltration and nerve block including caudal and epidural use. It is sterile, nonpyrogenic, with preservatives sodium chloride and pH adjusted to approximately 6.5. Manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Xylocaine MPF 20 mg/mL (2%) lidocaine hydrochloride injection solution in a 2 mL single dose vial. Label indicates use for infiltration and nerve block including caudal and epidural routes. Manufactured by Fresenius Kabi USA, LLC in Lake Zurich, IL. The label includes an NDC barcode, batch code, and methyparaben-free claim.*
FDA Label Image

Package Label – Principal Display Panel – Xylocaine – Mpf 2 mL Single Dose Vial Tray Label (Xyl03 0002 09)

Package Label – Principal Display Panel – Xylocaine – Mpf 2 mL Single Dose Vial Tray Label (Xyl03 0002 09)
Label for Xylocaine-MPF (Lidocaine HCl Injection, USP) 2% injection solution, containing 40 mg per 2 mL (20 mg per mL). It is indicated for infiltration and nerve block including caudal and epidural use. The package contains 25 single-dose 2 mL vials and is labeled as methylparaben free. The label includes storage instructions, sterilization notes, and the Fresenius Kabi USA, LLC manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.